SCHEMBL6206360

SCHEMBL6206360

CCNCc1ccc(CNC(=O)c2c[nH]c3c(Cl)cccc3c2=O)cc1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 10/20 0.51
ADORA1 P30542 5/20 0.51
POLB P06746 4/20 0.50
RAB9A P51151 3/20 0.50
ALDH1A1 P00352 3/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
NR4A2 P43354 1/20 0.48
NPC1 O15118 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
HPGD P15428 1/20 0.48
CYP2C19 P33261 1/20 0.48
MAPK10 P53779 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
HSD17B10 Q99714 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6207258 0.94 POLB (0.51) ADORA2AADORA1POLBRAB9AALDH1A1
SCHEMBL6206374 0.86 ADORA2A (0.58) ADORA2AADORA1POLBRAB9AALDH1A1
SCHEMBL6224870 0.81 CFTR (0.62) ADORA2AADORA1POLBRAB9ANPC1
Hydrochloric Acid SCHEMBL6205300 0.81 CFTR (0.61) ADORA2AADORA1POLBRAB9ANPC1
SCHEMBL6206009 0.79 HPGD (0.58) POLBRAB9AALDH1A1NPC1HPGD
SCHEMBL6205349 0.79 NHERF1 (0.65) ADORA2AADORA1POLBSMN1; SMN2
SCHEMBL6207242 0.79 ADORA2A (0.47) ADORA2AADORA1
SCHEMBL29050126 0.78 ALDH1A1 (0.60) POLBRAB9AALDH1A1MEN1KMT2A
SCHEMBL6206241 0.77 RAB9A (0.48) ADORA2AADORA1POLBRAB9AALDH1A1
SCHEMBL6197498 0.77 ADORA2A (0.61) ADORA2AADORA1POLBRAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177177-B1 SUBSTITUTED 4-OXO-QUINOLINE-3-CARBOXAMIDES: GABA BRAIN RECEPTOR LIGANDS NEUROGEN CORP (US) 2005-02-23 EP claimed